Skip to main content
Skip to main content
HUM logo

Humana Inc. (HUM)

$396.75 $-12.67 (-3.09%) |Strong · 79
Bottom line: STRONG BUY — our Council read (79/100) and AI Score (79/100) broadly agree.
MCap: $47.63B| P/E Ratio: 39.3| Vol: 1.39M| Target: $222.23 (-44.0%)| 52-wk range: $163.11 – $380.86
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Humana Inc. (HUM) trades at $396.75 with AI Score 79/100 (Grade A). Humana Inc. is a health and well-being company in the United States, offering medical and supplemental benefit plans. Market cap: $47.63B, Sector: Healthcare.

Price live · AI analysis from May 10, 2026
Humana Inc. is a health and well-being company in the United States, offering medical and supplemental benefit plans. It operates through Retail, Group and Specialty, and Healthcare Services segments, serving approximately 17 million members in medical benefit plans and 5 million in specialty products.

HUM stock analysis for 2026: Analysts have set a consensus price target of $222.23 for Humana Inc., suggesting 44.0% downside from the current price of $396.75. The AI MoonshotScore is 79/100, indicating a strong bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Council Score · Weighted Average of 3 Disciplines
STRONG BUY 79/100 · A

HUM: 1/1 perspectives are bullish.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Humana Inc. (HUM) Healthcare & Pipeline Overview

CEOJames A. Rechtin
Employees65680
HeadquartersLouisville, KY, US
IPO Year1981

Humana Inc. is a leading health and well-being company providing medical and supplemental benefit plans across the United States. Operating through multiple segments, Humana serves a large membership base with diverse healthcare solutions, positioning itself in a competitive healthcare landscape with a focus on integrated services and government partnerships.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for HUM?

Humana Inc. presents a mixed investment case. The company's established presence in the Medicare Advantage market and its integrated healthcare service offerings provide a stable revenue base. The company's P/E ratio is 39.3, and the dividend yield is 1.29%. Growth catalysts include expansion of its Medicare and Medicaid services, and further development of its Healthcare Services segment. Potential risks include regulatory changes in the healthcare industry and increasing competition. With a market capitalization of $47.63B, Humana's financial performance and strategic initiatives warrant close monitoring.

Based on FMP financials and quantitative analysis

HUM Key Highlights

  • Humana has approximately 17 million members in medical benefit plans as of December 31, 2021, demonstrating a significant market presence.
  • The company's gross margin is 14.0%, indicating its ability to manage the costs associated with its healthcare services.
  • Humana's profit margin is 0.8%, reflecting the competitive pressures and operational expenses within the healthcare industry.
  • The company's beta is 0.45, suggesting lower volatility compared to the overall market.
  • Humana offers medical and supplemental benefit plans, including Medicare Advantage, Medicaid, and commercial insurance, diversifying its revenue streams.

Who Are HUM's Competitors?

HUM is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
HLN Haleon plc $9.82 +4.47% $43.28B 49
ALC Alcon Inc. $69.66 +4.25% $33.97B 51
ONC BeOne Medicines Ltd. $297.65 +2.38% $31.81B 97
A Agilent Technologies, Inc. $130.69 -2.02% $36.91B 83
IQV IQVIA Holdings Inc. $207.04 +1.89% $34.55B 67
ALHC Alignment Healthcare, Inc. $23.80 -0.87% $4.92B 52
GTS Triple-S Management Corporation $35.99 +1.04% 52
CNC Centene Corporation $67.86 -0.72% $33.51B 49

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are HUM's Key Strengths?

  • Large membership base with approximately 17 million members in medical benefit plans.
  • Diversified business segments, including Retail, Group and Specialty, and Healthcare Services.
  • Strong presence in the Medicare Advantage market.
  • Integrated care delivery model that combines health insurance with healthcare services.

What Are HUM's Weaknesses?

  • Relatively low profit margin of 0.8%.
  • Exposure to regulatory changes and healthcare policy risks.
  • Dependence on government contracts for a significant portion of revenue.
  • Competitive pressures from other large health insurers.

What Could Drive HUM Stock Higher?

  • Expansion of Medicare Advantage plans into new geographic markets.
  • Development and rollout of new digital health tools and telehealth services.
  • Potential acquisitions or partnerships to expand service offerings.
  • Growth in the Healthcare Services segment, including home health and pharmacy solutions.
  • Government policy changes impacting Medicare and Medicaid reimbursement rates.

What Are the Key Risks for HUM?

  • Rich valuation — a P/E of 39.3 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
  • Regulatory changes in the healthcare industry, such as changes to the Affordable Care Act.
  • Increasing competition from other health insurers and healthcare providers.
  • Rising healthcare costs and medical loss ratios.
  • Economic downturns that could reduce enrollment in commercial health plans.
  • Cybersecurity threats and data breaches that could compromise member information.

What Are the Growth Opportunities for HUM?

  • Growth opportunity 1: Expansion of Medicare Advantage offerings represents a significant growth opportunity for Humana. The Medicare Advantage market is projected to continue growing as more seniors opt for managed care plans. Humana can leverage its established brand and provider networks to increase its market share in key geographic regions. The increasing demand for specialized care within Medicare Advantage, such as chronic disease management programs, also presents opportunities for Humana to differentiate its offerings.
  • Growth opportunity 2: Growth in Medicaid contracts represents a significant opportunity for Humana. The company has contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. Humana can expand its Medicaid business by bidding on new contracts and improving its service delivery. The increasing number of individuals eligible for Medicaid due to economic factors and policy changes drives this growth.
  • Growth opportunity 3: Development of Healthcare Services segment, including pharmacy solutions, provider services, and home solutions, offers substantial growth potential. The market for home healthcare services is expanding due to the aging population and the desire for more convenient and cost-effective care options. Humana can leverage its existing infrastructure and partnerships to expand its home health offerings and capture a larger share of this market. This segment allows Humana to diversify its revenue streams and enhance its integrated care model.
  • Growth opportunity 4: Leveraging technology to enhance member engagement and improve health outcomes is a key growth driver. Investing in telehealth platforms, digital health tools, and data analytics can enable Humana to provide more personalized and proactive care. The increasing adoption of digital health solutions by consumers and providers creates opportunities for Humana to improve member satisfaction, reduce costs, and drive better health outcomes. This includes remote monitoring, virtual consultations, and AI-powered care management.
  • Growth opportunity 5: Strategic partnerships and acquisitions can accelerate Humana's growth in key markets and service areas. Collaborating with healthcare providers, technology companies, and other organizations can expand Humana's capabilities and reach. Targeted acquisitions can add new services, technologies, or geographic presence. For example, acquiring a home healthcare company or a telehealth platform can enhance Humana's integrated care offerings and expand its market reach.

What Opportunities Does HUM Have?

  • Expansion of Medicare Advantage offerings to capture a larger share of the growing market.
  • Growth in Medicaid contracts and expansion into new states.
  • Development of Healthcare Services segment, including pharmacy, provider, and home health services.
  • Leveraging technology to enhance member engagement and improve health outcomes.

What Threats Does HUM Face?

  • Changes in healthcare regulations and reimbursement rates.
  • Increasing competition from other health insurers and healthcare providers.
  • Rising healthcare costs and medical loss ratios.
  • Economic downturns that could reduce enrollment in commercial health plans.

What Are HUM's Competitive Advantages?

  • Established brand reputation and market presence in the health insurance industry.
  • Extensive provider network and relationships with healthcare providers.
  • Expertise in managing government-sponsored healthcare programs, such as Medicare and Medicaid.
  • Integrated care delivery model that combines health insurance with healthcare services.
  • Scale and efficiency in administering health plans and processing claims.

What Does HUM Do?

Founded in 1961 and headquartered in Louisville, Kentucky, Humana Inc. has evolved into a major player in the U.S. health and well-being sector. Originally a nursing home company, Humana transitioned into health insurance in the 1980s. Today, the company operates through three primary segments: Retail, Group and Specialty, and Healthcare Services. The Retail segment offers a variety of medical and supplemental benefit plans to individuals, including Medicare Advantage plans, prescription drug plans, and other health and wellness solutions. The Group and Specialty segment provides commercial fully insured medical and specialty health insurance benefits, such as dental, vision, and other supplemental health benefits, to employer groups. Humana also administers military services like the TRICARE T2017 East Region contract. The Healthcare Services segment delivers pharmacy solutions, provider services, and home solutions, including home health services, to both its health plan members and third parties. As of December 31, 2021, Humana served approximately 17 million members in medical benefit plans and approximately 5 million members in specialty products. Humana's strategic focus includes expanding its integrated care offerings and leveraging technology to improve member experiences and health outcomes.

What Products and Services Does HUM Offer?

  • Offers medical benefit plans to individuals, including Medicare Advantage plans.
  • Provides supplemental benefit plans, such as dental and vision insurance.
  • Administers the Limited Income Newly Eligible Transition prescription drug plan program for the Centers for Medicare and Medicaid Services.
  • Contracts with states to provide Medicaid, dual eligible, and long-term support services benefits.
  • Offers commercial fully insured medical and specialty health insurance benefits to employer groups.
  • Provides administrative services only products to individuals and employer groups.
  • Offers military services, such as the TRICARE T2017 East Region contract.
  • Provides pharmacy solutions, provider services, and home solutions services.

How Does HUM Make Money?

  • Generates revenue from premiums paid by members for medical and supplemental benefit plans.
  • Earns fees from administering government-sponsored healthcare programs, such as Medicare and Medicaid.
  • Receives payments for providing healthcare services, including pharmacy, provider, and home health services.
  • Derives income from administrative services provided to employer groups and other organizations.

What Industry Does HUM Operate In?

Humana operates in the dynamic and highly regulated U.S. healthcare industry. The industry is characterized by increasing demand for healthcare services, driven by an aging population and rising prevalence of chronic diseases. The competitive landscape includes major players like UnitedHealth Group and CVS Health, as well as regional health insurers. Market trends include a shift towards value-based care, increased adoption of telehealth, and growing focus on preventive care and wellness programs. Humana's integrated care delivery model and focus on Medicare Advantage position it to capitalize on these trends.

Who Are HUM's Key Customers?

  • Individuals seeking medical and supplemental health insurance coverage.
  • Seniors eligible for Medicare Advantage plans.
  • Low-income individuals and families eligible for Medicaid benefits.
  • Employer groups offering health insurance benefits to their employees.
  • Government agencies contracting for healthcare administration services.
AI Confidence: 73% Updated: May 10, 2026

Company Profile

Humana Inc. operates in the Medical - Healthcare Plans industry within the Healthcare sector. It is headquartered in Louisville, US. The company is led by CEO James A. Rechtin. HUM has traded publicly since 1981.

How Humana Inc. Is Valued

Humana Inc. carries a market capitalization of $47.63B, placing it in the large-cap category. Relative to its peer group, HUM's quantitative score of 79/100 is roughly in line with the peer average of 69/100.

ROE 6%Key Financial Metrics

Return on equity for Humana Inc. stands at 6.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.0%, showing how much profit it generates from its asset base. HUM trades at a trailing price-to-earnings ratio of 39.35, above the Healthcare sector average of ~23x. Its free cash flow yield is 2.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.26 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.4%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 8/9Financial Health

Humana Inc.'s Piotroski F-Score is 8/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 4.27 places it in the safe zone, indicating low near-term bankruptcy risk.

FY2026 estForward Outlook

Wall Street analysts project Humana Inc. revenue of about $162.10B for fiscal 2026, with EPS near $8.85. The estimate reflects 16 contributing analysts.

Net buyingInsider Activity

Over the past six months, Humana Inc. insiders filed 14 SEC Form 4 transactions — 1 sales and 13 purchases. On net that is roughly 113K shares acquired (about $70K) — insiders putting money in tends to read as conviction.

HUM Financials

Fundamental Snapshot

Revenue Growth (FY)
+10.1%
Net Income Growth (FY)
-1.6%
EPS Growth (FY)
-1.4%
Free Cash Flow Growth (FY)
-84.3%
P/E (TTM)
42.3
Return on Equity (TTM)
+6.2%
Current Ratio
1.3
EV/EBITDA (TTM)
19.9

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Large membership base with approximately 17 million members in medical benefit plans.
  • Diversified business segments, including Retail, Group and Specialty, and Healthcare Services.
  • Strong presence in the Medicare Advantage market.
  • Integrated care delivery model that combines health insurance with healthcare services.

Bear Case

  • Relatively low profit margin of 0.8%.
  • Exposure to regulatory changes and healthcare policy risks.
  • Dependence on government contracts for a significant portion of revenue.
  • Competitive pressures from other large health insurers.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

From the Earnings Call

“First of all, our member growth trajectory is on track. Now we will, and we have and we will continue to manage distribution and growth dynamically if things change, but our growth trajectory is on track. Second, I want to emphasize that membership, both new and returning, is performing as expected 3 months into the year.”

— James Rechtin, CEO

“Our outlook on BY '28 Stars has not changed. We continue to be confident that we're on the right track to return to top quartile Stars results in BY '28. For BY '29 Stars, we are seeing a strong early start.”

— James Rechtin, CEO

HUM Q1 FY2026 earnings call transcript · 2026-04-29

HUM Latest News

HUM Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HUM.

Price Targets

Consensus target: $222.23

HUM MoonshotScore

79/100

What does this score mean?

The MoonshotScore rates HUM's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Latest Humana Inc. Analysis

Leadership: James A. Rechtin

CEO

James A. Rechtin serves as the CEO of Humana Inc., leading a workforce of 65,680 employees. His career spans various leadership roles within the healthcare industry, bringing extensive experience in strategic planning, operational management, and healthcare innovation. Rechtin's background includes a strong focus on improving healthcare delivery and enhancing member experiences. He is known for his expertise in navigating the complexities of the healthcare landscape and driving growth through strategic initiatives.

Track Record: Under James A. Rechtin's leadership, Humana has focused on expanding its integrated care model and enhancing its technology capabilities. Key achievements include strategic partnerships to improve member engagement and health outcomes. He has also overseen efforts to navigate regulatory changes and adapt to evolving market dynamics. His tenure has been marked by a commitment to innovation and a focus on delivering value to members and shareholders.

HUM Healthcare Stock FAQ

What does Humana Inc. do?

Humana Inc. operates as a health and well-being company in the United States, providing a range of medical and supplemental benefit plans. The company focuses on delivering integrated care through its Retail, Group and Specialty, and Healthcare Services segments. Humana offers Medicare Advantage plans, Medicaid benefits, commercial insurance, and healthcare services such as pharmacy solutions and home health services. The company aims to improve the health and well-being of its members through innovative care models and technology-enabled solutions.

What do analysts say about HUM stock?

Analyst consensus on Humana Inc. (HUM) reflects a mixed outlook, considering both its established market position and potential challenges. Key valuation metrics, such as the P/E ratio of 39.3, are factored into their assessments. Growth considerations include the expansion of Medicare Advantage plans and the development of the Healthcare Services segment. Analysts also monitor regulatory changes and competitive pressures within the healthcare industry. These factors collectively influence their ratings and price targets for HUM stock.

What are the main risks for HUM?

Humana faces several key risks, including regulatory changes in the healthcare industry, such as potential changes to the Affordable Care Act and Medicare/Medicaid reimbursement rates. Increasing competition from other health insurers and healthcare providers could impact market share and profitability. Rising healthcare costs and medical loss ratios pose a challenge to maintaining financial performance. Economic downturns could reduce enrollment in commercial health plans, affecting revenue. Cybersecurity threats and data breaches also represent a significant risk to member information and company reputation.

What are the key factors to evaluate for HUM?

Humana Inc. (HUM) holds an AI score of 79/100 (high). P/E: 39.3x vs the S&P 500's ~20-25x. Analysts target $222.23 (-44%). Not financial advice.

How frequently does HUM data refresh on this page?

HUM prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven HUM's recent stock price performance?

Humana Inc. (HUM) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Large membership base with approximately 17 million members in medical benefit plans. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider HUM overvalued or undervalued right now?

Humana Inc. (HUM) trades at 39.3x earnings. Analysts target $222.23 (-44%) — downside risk seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying HUM?

Before investing in Humana Inc. (HUM), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data as of 2026-05-10.
  • Financial metrics are based on the most recent available data.
  • Future performance is subject to market conditions and company-specific factors.
Data Sources

Popular Stocks